Buruli Ulcer: History and Disease Burden

Katharina Röltgen, Gerd Pluschke, Gerd Pluschke, Katharina Röltgen, Katharina Röltgen, Gerd Pluschke, Gerd Pluschke, Katharina Röltgen

Excerpt

Buruli ulcer (BU) is a neglected, debilitating skin disease caused by infection with Mycobacterium ulcerans. After the first definite description in 1948, M. ulcerans infections have been reported from 34 countries, mainly with tropical and subtropical climates. Following a peak of 5954 reported BU cases globally in 2004 the number of new recorded cases has been decreasing over the past years. In 2016, a total of 1952 BU cases were reported to the World Health Organization (WHO) from twelve different countries. Underreporting is considered likely, as BU mostly affects populations in remote areas with limited access to the formal health sector. Although transmission pathways of M. ulcerans are still unclear, infection foci are closely associated with wetlands. Considering that M. ulcerans has evolved from the fish pathogen M. marinum, involvement of an environmental niche is strongly suggestive. The key event for the emergence of M. ulcerans as a species highly pathogenic for humans appears to be the acquisition of a plasmid, bearing genes encoding polyketide synthases and polyketide-modifying enzymes involved in the biosynthesis of a unique macrolide toxin, named mycolactone. The cytotoxic and immunosuppressive properties of mycolactone account for much of the pathology of BU, which is characterized by the formation of chronic, necrotizing, ulcerative skin lesions. In the further course of its reductive evolution, M. ulcerans has diverged into at least two principal niche-adapted lineages connected with different patterns of BU case distribution. Strains of the classical lineage are responsible for BU foci in Africa and Australia that are typically characterized by high local prevalence. In contrast, scattered, sporadic BU cases recorded in Asia and the Americas are caused by strains of the ancestral lineage, which also comprises globally distributed fish and frog pathogens. Adaptation of these divergent mycolactone-producing mycobacterial lineages to different ecological habitats seems likely. Limited knowledge on definite reservoirs and potential vectors as well as the lack of a vaccine hamper the control of BU. Therefore, early identification and adequate treatment of patients are currently the most important measures to prevent the debilitating consequences of the disease.

Copyright 2019, The Author(s).

References

    1. Cook A (1897) The Mengo hospital notes. Makere College Medical School Library, Kampala
    1. MacCallum P, Tolhurst JC et al (1948) A new mycobacterial infection in man. J Pathol Bacteriol 60(1):93–122
    1. Parson W (1999) Mycobacterium ulcerans. Lancet 354(9196):2171
    1. Janssens PG, Quertinmont MJ, Sieniawski J, Gatti F (1959) Necrotic tropical ulcers and mycobacterial causative agents. Trop Geogr Med 11:293–312
    1. Clancey JK, Dodge OG, Lunn HF, Oduori ML (1961) Mycobacterial skin ulcers in Uganda. Lancet 2(7209):951–954
    1. Lunn HF, Connor DH, Wilks NE, Barnley GR, Kamunvi F, Clancey JK et al (1965) Buruli (Mycobacterial) ulceration in Uganda. (a new focus of Buruli ulcer in Madi District, Uganda): report of a field study. East Afr Med J 42:275–288
    1. The Uganda Buruli Group (1971) Epidemiology of Mycobacterium ulcerans infection (Buruli ulcer) at Kinyara, Uganda. Trans R Soc Trop Med Hyg 65(6):763–775
    1. The Uganda Buruli Group (1970) Clinical features and treatment of pre-ulcerative Buruli lesions (Mycobacterium ulcerans infection). Report II of the Uganda Buruli group. Br Med J 2(5706):390–393
    1. Smith JH (1970) Epidemiologic observations on cases of Buruli ulcer seen in a hospital in the lower Congo. Am J Trop Med Hyg. 19(4):657–663
    1. Oluwasanmi JO, Solankee TF, Olurin EO, Itayemi SO, Alabi GO, Lucas AO (1976) Mycobacterium ulcerans (Buruli) skin ulceration in Nigeria. Am J Trop Med Hyg 25(1):122–128
    1. Burchard GD, Bierther M (1986) Buruli ulcer: clinical pathological study of 23 patients in Lambarene, Gabon. Trop Med Parasitol 37(1):1–8
    1. van der Werf TS, van der Graaf WT, Groothuis DG, Knell AJ (1989) Mycobacterium ulcerans infection in Ashanti region, Ghana. Trans R Soc Trop Med Hyg 83(3):410–413
    1. Amofah GK, Sagoe-Moses C, Adjei-Acquah C, Frimpong EH (1993) Epidemiology of Buruli ulcer in Amansie west district, Ghana. Trans R Soc Trop Med Hyg 87(6):644–645
    1. Muelder K, Nourou A (1990) Buruli ulcer in Benin. Lancet 336(8723):1109–1111
    1. Darie H, Le Guyadec T, Touze JE (1993) Epidemiological and clinical aspects of Buruli ulcer in Ivory Coast. 124 recent cases. Bull Soc Pathol Exot 86(4):272–276
    1. Marston BJ, Diallo MO, Horsburgh CR Jr, Diomande I, Saki MZ, Kanga JM et al (1995) Emergence of Buruli ulcer disease in the Daloa region of cote d’Ivoire. Am J Trop Med Hyg 52(3):219–224
    1. Johnson PD, Veitch MG, Leslie DE, Flood PE, Hayman JA (1996) The emergence of Mycobacterium ulcerans infection near Melbourne. Med J Aust 164(2):76–78
    1. Veitch MG, Johnson PD, Flood PE, Leslie DE, Street AC, Hayman JA (1997) A large localized outbreak of Mycobacterium ulcerans infection on a temperate southern Australian island. Epidemiol Infect 119(3):313–318
    1. Igo JD, Murthy DP (1988) Mycobacterium ulcerans infections in Papua New Guinea: correlation of clinical, histological, and microbiologic features. Am J Trop Med Hyg. 38(2):391–392
    1. Röltgen K, Pluschke G (2015) Epidemiology and disease burden of Buruli ulcer: a review. Res Rep Trop Med 2015(6):59–73
    1. Stinear TP, Seemann T, Pidot S, Frigui W, Reysset G, Garnier T et al (2007) Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer. Genome Res 17(2):192–200
    1. Qi W, Kaser M, Roltgen K, Yeboah-Manu D, Pluschke G (2009) Genomic diversity and evolution of Mycobacterium ulcerans revealed by next-generation sequencing. PLoS Pathog 5(9):e1000580
    1. Mve-Obiang A, Lee RE, Portaels F, Small PL (2003) Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence. Infect Immun 71(2):774–783
    1. Mve-Obiang A, Lee RE, Umstot ES, Trott KA, Grammer TC, Parker JM et al (2005) A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin. Infect Immun 73(6):3307–3312
    1. Ranger BS, Mahrous EA, Mosi L, Adusumilli S, Lee RE, Colorni A et al (2006) Globally distributed mycobacterial fish pathogens produce a novel plasmid-encoded toxic macrolide, mycolactone F. Infect Immun 74(11):6037–6045
    1. Doig KD, Holt KE, Fyfe JA, Lavender CJ, Eddyani M, Portaels F et al (2012) On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer. BMC Genomics 13:258
    1. Kaser M, Rondini S, Naegeli M, Stinear T, Portaels F, Certa U et al (2007) Evolution of two distinct phylogenetic lineages of the emerging human pathogen Mycobacterium ulcerans. BMC Evol Biol 7:177
    1. Eddyani M, De Jonckheere JF, Durnez L, Suykerbuyk P, Leirs H, Portaels F (2008) Occurrence of free-living amoebae in communities of low and high endemicity for Buruli ulcer in southern Benin. Appl Environ Microbiol 74(21):6547–6553
    1. Gryseels S, Amissah D, Durnez L, Vandelannoote K, Leirs H, De Jonckheere J et al (2012) Amoebae as potential environmental hosts for Mycobacterium ulcerans and other mycobacteria, but doubtful actors in Buruli ulcer epidemiology. PLoS Negl Trop Dis 6(8):e1764
    1. Amissah NA, Gryseels S, Tobias NJ, Ravadgar B, Suzuki M, Vandelannoote K et al (2014) Investigating the role of free-living amoebae as a reservoir for Mycobacterium ulcerans. PLoS Negl Trop Dis 8(9):e3148
    1. Trott KA, Stacy BA, Lifland BD, Diggs HE, Harland RM, Khokha MK et al (2004) Characterization of a Mycobacterium ulcerans-like infection in a colony of African tropical clawed frogs (Xenopus tropicalis). Comp Med 54(3):309–317
    1. Rhodes MW, Kator H, McNabb A, Deshayes C, Reyrat JM, Brown-Elliott BA et al (2005) Mycobacterium pseudoshottsii sp. nov., a slowly growing chromogenic species isolated from Chesapeake Bay striped bass (Morone saxatilis). Int J Syst Evol Microbiol 55(Pt 3):1139–1147
    1. Stragier P, Hermans K, Stinear T, Portaels F (2008) First report of a mycolactone-producing Mycobacterium infection in fish agriculture in Belgium. FEMS Microbiol Lett 286(1):93–95
    1. Yoshida M, Nakanaga K, Ogura Y, Toyoda A, Ooka T, Kazumi Y et al (2016) Complete genome sequence of Mycobacterium ulcerans subsp. shinshuense. Genome Announc 4(5):e01050–e01016
    1. Yip MJ, Porter JL, Fyfe JA, Lavender CJ, Portaels F, Rhodes M et al (2007) Evolution of Mycobacterium ulcerans and other mycolactone-producing mycobacteria from a common Mycobacterium marinum progenitor. J Bacteriol 189(5):2021–2029
    1. Morris A, Gozlan R, Marion E, Marsollier L, Andreou D, Sanhueza D et al (2014) First detection of Mycobacterium ulcerans DNA in environmental samples from South America. PLoS Negl Trop Dis 8(1):e2660
    1. Ohtsuka M, Kikuchi N, Yamamoto T, Suzutani T, Nakanaga K, Suzuki K et al (2014) Buruli ulcer caused by Mycobacterium ulcerans subsp shinshuense: a rare case of familial concurrent occurrence and detection of insertion sequence 2404 in Japan. JAMA Dermatol 150(1):64–67
    1. Boleira M, Lupi O, Lehman L, Asiedu KB, Kiszewski AE (2010) Buruli ulcer. An Bras Dermatol 85(3):281–298. quiz 99-301
    1. Guerra H, Palomino JC, Falconi E, Bravo F, Donaires N, Van Marck E et al (2008) Mycobacterium ulcerans disease, Peru. Emerg Infect Dis 14(3):373–377
    1. dos Santos VM, Noronha FL, Vicentina EC, Lima CC (2007) Mycobacterium ulcerans infection in Brazil. Med J Aust 187(1):63–64
    1. Coloma JN, Navarrete-Franco G, Iribe P, Lopez-Cepeda LD (2005) Ulcerative cutaneous mycobacteriosis due to Mycobacterium ulcerans: report of two Mexican cases. Int J Lepr Other Mycobact Dis 73(1):5–12
    1. Yotsu RR, Nakanaga K, Hoshino Y, Suzuki K, Ishii N (2012) Buruli ulcer and current situation in Japan: a new emerging cutaneous Mycobacterium infection. J Dermatol 39(7):587–593
    1. Faber WR, Arias-Bouda LM, Zeegelaar JE, Kolk AH, Fonteyne PA, Toonstra J et al (2000) First reported case of Mycobacterium ulcerans infection in a patient from China. Trans R Soc Trop Med Hyg 94(3):277–279
    1. Steffen CM, Freeborn H (2016) Mycobacterium ulcerans in the Daintree 2009-2015 and the mini-epidemic of 2011. ANZ J Surg 88(4):E289–E293
    1. Reid IS (1967) Mycobacterium ulcerans infection: a report of 13 cases at the Port Moresby general hospital, Papua. Med J Aust 1(9):427–431
    1. Radford AJ (1974) Mycobacterium Ulcerans infections in Papua New Guinea. P N G Med J 17(2):145–149
    1. Merritt RW, Walker ED, Small PL, Wallace JR, Johnson PD, Benbow ME et al (2010) Ecology and transmission of Buruli ulcer disease: a systematic review. PLoS Negl Trop Dis 4(12):e911
    1. Vandelannoote K, Durnez L, Amissah D, Gryseels S, Dodoo A, Yeboah S et al (2010) Application of real-time PCR in Ghana, a Buruli ulcer-endemic country, confirms the presence of Mycobacterium ulcerans in the environment. FEMS Microbiol Lett 304(2):191–194
    1. Bratschi MW, Ruf MT, Andreoli A, Minyem JC, Kerber S, Wantong FG et al (2014) Mycobacterium ulcerans persistence at a village water source of Buruli ulcer patients. PLoS Negl Trop Dis 8(3):e2756
    1. Fyfe JA, Lavender CJ, Handasyde KA, Legione AR, O’Brien CR, Stinear TP et al (2010) A major role for mammals in the ecology of Mycobacterium ulcerans. PLoS Negl Trop Dis 4(8):e791
    1. Röltgen K, Pluschke G (2015) Mycobacterium ulcerans disease (Buruli ulcer): potential reservoirs and vectors. Curr Clin Microbiol Rep 2(1):35–43
    1. Roltgen K, Pluschke G, Johnson PDR, Fyfe J (2017) Mycobacterium ulcerans DNA in bandicoot excreta in Buruli ulcer-endemic area, northern Queensland, Australia. Emerg Infect Dis 23(12):2042–2045
    1. Durnez L, Suykerbuyk P, Nicolas V, Barriere P, Verheyen E, Johnson CR et al (2010) Terrestrial small mammals as reservoirs of Mycobacterium ulcerans in Benin. Appl Environ Microbiol 76(13):4574–4577
    1. Christie M (1987) Suspected Mycobacterium ulcerans disease in Kiribati. Med J Aust 146(11):600–604
    1. Pettit JH, Marchette NJ, Rees RJ (1966) Mycobacterium ulcerans infection. Clinical and bacteriological study of the first cases recognized in South East Asia. Br J Dermatol 78(4):187–197
    1. N’krumah RT, Kone B, Cisse G, Tanner M, Utzinger J, Pluschke G et al (2016) Characteristics and epidemiological profile of Buruli ulcer in the district of Tiassale, south Cote d’Ivoire. Acta Trop 175:138–144
    1. Hospers IC, Wiersma IC, Dijkstra PU, Stienstra Y, Etuaful S, Ampadu EO et al (2005) Distribution of Buruli ulcer lesions over body surface area in a large case series in Ghana: uncovering clues for mode of transmission. Trans R Soc Trop Med Hyg 99(3):196–201
    1. Mensah-Quainoo E, Yeboah-Manu D, Asebi C, Patafuor F, Ofori-Adjei D, Junghanss T et al (2008) Diagnosis of Mycobacterium ulcerans infection (Buruli ulcer) at a treatment centre in Ghana: a retrospective analysis of laboratory results of clinically diagnosed cases. Tropical Med Int Health 13(2):191–198
    1. Yeboah-Manu D, Aboagye SY, Asare P, Asante-Poku A, Ampah K, Danso E et al (2018) Laboratory confirmation of Buruli ulcer cases in Ghana, 2008-2016. PLoS Negl Trop Dis 12(6):e0006560
    1. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, Guedenon A et al (2004) Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, southern Benin, 1997-2001. Emerg Infect Dis 10(8):1391–1398
    1. Vincent QB, Ardant MF, Adeye A, Goundote A, Saint-Andre JP, Cottin J et al (2014) Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study. Lancet Glob Health 2(7):e422–e430
    1. Capela C, Sopoh GE, Houezo JG, Fiodessihoue R, Dossou AD, Costa P et al (2015) Clinical epidemiology of Buruli ulcer from Benin (2005-2013): effect of time-delay to diagnosis on clinical forms and severe phenotypes. PLoS Negl Trop Dis 9(9):e0004005
    1. Noeske J, Kuaban C, Rondini S, Sorlin P, Ciaffi L, Mbuagbaw J et al (2004) Buruli ulcer disease in Cameroon rediscovered. Am J Trop Med Hyg 70(5):520–526
    1. Bratschi MW, Bolz M, Minyem JC, Grize L, Wantong FG, Kerber S et al (2013) Geographic distribution, age pattern and sites of lesions in a cohort of Buruli ulcer patients from the Mape Basin of Cameroon. PLoS Negl Trop Dis 7(6):e2252
    1. Mavinga Phanzu D, Suykerbuyk P, Saunderson P, Ngwala Lukanu P, Masamba Minuku JB, Imposo DB et al (2013) Burden of Mycobacterium ulcerans disease (Buruli ulcer) and the underreporting ratio in the territory of Songololo, Democratic Republic of Congo. PLoS Negl Trop Dis 7(12):e2563
    1. Bretzel G, Huber KL, Kobara B, Beissner M, Piten E, Herbinger KH et al (2011) Laboratory confirmation of Buruli ulcer disease in Togo, 2007-2010. PLoS Negl Trop Dis 5(7):e1228
    1. Marion E, Obvala D, Babonneau J, Kempf M, Asiedu KB, Marsollier L (2014) Buruli ulcer disease in Republic of the Congo. Emerg Infect Dis 20(6):1070–1072
    1. Marion E, Carolan K, Adeye A, Kempf M, Chauty A, Marsollier L (2015) Buruli ulcer in South Western Nigeria: a retrospective cohort study of patients treated in Benin. PLoS Negl Trop Dis 9(1):e3443
    1. Douine M, Gozlan R, Nacher M, Dufour J, Reynaud Y, Elguero E et al (2017) Mycobacterium ulcerans infection (Buruli ulcer) in French Guiana, South America, 1969–2013: an epidemiological study. Lancet Planet Health 1(2):e65–e73
    1. Steffen CM, Smith M, McBride WJ (2010) Mycobacterium ulcerans infection in North Queensland: the ‘Daintree ulcer’. ANZ J Surg 80(10):732–736
    1. Boyd SC, Athan E, Friedman ND, Hughes A, Walton A, Callan P et al (2012) Epidemiology, clinical features and diagnosis of Mycobacterium ulcerans in an Australian population. Med J Aust 196(5):341–344
    1. Yerramilli A, Tay EL, Stewardson AJ, Kelley PG, Bishop E, Jenkin GA et al (2017) The location of Australian Buruli ulcer lesions-implications for unravelling disease transmission. PLoS Negl Trop Dis 11(8):e0005800
    1. Ampah KA, Asare P, Binnah DD, Maccaulley S, Opare W, Roltgen K et al (2016) Burden and historical trend of Buruli ulcer prevalence in selected communities along the Offin River of Ghana. PLoS Negl Trop Dis 10(4):e0004603
    1. Debacker M, Portaels F, Aguiar J, Steunou C, Zinsou C, Meyers W et al (2006) Risk factors for Buruli ulcer, Benin. Emerg Infect Dis 12(9):1325–1331
    1. Johnson PD, Azuolas J, Lavender CJ, Wishart E, Stinear TP, Hayman JA et al (2007) Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, southeastern Australia. Emerg Infect Dis 13(11):1653–1660
    1. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, Scott JT et al (2004) Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop. Med Int Health 9(12):1297–1304
    1. Roltgen K, Bratschi MW, Ross A, Aboagye SY, Ampah KA, Bolz M et al (2014) Late onset of the serological response against the 18 kDa small heat shock protein of Mycobacterium ulcerans in children. PLoS Negl Trop Dis 8(5):e2904
    1. Ampah KA, Nickel B, Asare P, Ross A, De-Graft D, Kerber S et al (2016) A Sero-epidemiological approach to explore transmission of mycobacterium ulcerans. PLoS Negl Trop Dis 10(1):e0004387
    1. Raghunathan PL, Whitney EA, Asamoa K, Stienstra Y, Taylor TH Jr, Amofah GK et al (2005) Risk factors for Buruli ulcer disease (Mycobacterium ulcerans infection): results from a case-control study in Ghana. Clin Infect Dis 40(10):1445–1453
    1. Quek TY, Athan E, Henry MJ, Pasco JA, Redden-Hoare J, Hughes A et al (2007) Risk factors for Mycobacterium ulcerans infection, southeastern Australia. Emerg Infect Dis 13(11):1661–1666
    1. Kenu E, Nyarko KM, Seefeld L, Ganu V, Kaser M, Lartey M et al (2014) Risk factors for buruli ulcer in Ghana-a case control study in the Suhum-Kraboa-Coaltar and Akuapem south districts of the eastern region. PLoS Negl Trop Dis 8(11):e3279
    1. WHO (2012) Treatment of Mycobacterium ulcerans disease (Buruli ulcer): guidance for health workers. World Health Organization, Geneva
    1. Chauty A, Ardant MF, Adeye A, Euverte H, Guedenon A, Johnson C et al (2007) Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease). Antimicrob Agents Chemother 51(11):4029–4035
    1. Marion E, Song OR, Christophe T, Babonneau J, Fenistein D, Eyer J et al (2014) Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways. Cell 157(7):1565–1576
    1. Morris A, Gozlan RE, Hassani H, Andreou D, Couppie P, Guegan JF (2014) Complex temporal climate signals drive the emergence of human water-borne disease. Emerg Microbes Infec 3:e56
    1. Hudman LE, Jackson RH (2003) Geography of travel & tourism, 4th edn. Thomson/Delmar Learning, Clifton Park. xi, 534 p., 8 p. of plates p
    1. Buultjens AH, Vandelannoote K, Meehan CJ, Eddyani M, de Jong BC, Fyfe JAM et al (2018) Comparative genomics shows Mycobacterium ulcerans migration and expansion has preceded the rise of Buruli ulcer in South-Eastern Australia. Appl Environ Microbiol 84(8):e02612–e02617
    1. Carson C, Lavender CJ, Handasyde KA, O’Brien CR, Hewitt N, Johnson PD et al (2014) Potential wildlife sentinels for monitoring the endemic spread of human buruli ulcer in south-East Australia. PLoS Negl Trop Dis 8(1):e2668
    1. Froidurot S, Diedhiou A (2017) Characteristics of wet and dry spells in the west African monsoon system. Atmos Sci Lett 18(3):125–131
    1. Guenang GM, Kamga FM (2012) Onset, retreat and length of the rainy season over Cameroon. Atmos Sci Lett 13(2):120–127
    1. Trubiano JA, Lavender CJ, Fyfe JA, Bittmann S, Johnson PD (2013) The incubation period of Buruli ulcer (Mycobacterium ulcerans infection). PLoS Negl Trop Dis 7(10):e2463
    1. Loftus MJ, Trubiano JA, Tay EL, Lavender CJ, Globan M, Fyfe JAM et al (2018) The incubation period of Buruli ulcer (Mycobacterium ulcerans infection) in Victoria, Australia - remains similar despite changing geographic distribution of disease. PLoS Negl Trop Dis 12(3):e0006323
    1. Landier J, Constantin de Magny G, Garchitorena A, Guegan JF, Gaudart J, Marsollier L et al (2015) Seasonal patterns of Buruli ulcer incidence, Central Africa, 2002-2012. Emerg Infect Dis 21(8):1414–1417
    1. Morse SS (1995) Factors in the emergence of infectious-diseases. Emerg Infect Dis 1(1):7–15
    1. Patz JA, Olson SH, Uejio CK, Gibbs HK (2008) Disease emergence from global climate and land use change. Med Clin N Am 92(6):1473
    1. Johnson PD, Veitch MG, Flood PE, Hayman JA (1995) Mycobacterium ulcerans infection on Phillip Island. Victoria Med J Aust 162(4):221–222
    1. Oluwasanmi JO, Itayemi SO, Alabi GO (1975) Buruli (mycobacterial) ulcers in Caucasians in Nigeria. Brit J Plast Surg 28(2):111–113
    1. Marion E, Landier J, Boisier P, Marsollier L, Fontanet A, Le Gall P et al (2011) Geographic expansion of Buruli ulcer disease, Cameroon. Emerg Infect Dis 17(3):551–553
    1. N’Krumah RTAS, Kone B, Cisse G, Tanner M, Utzinger J, Pluschke G et al (2017) Characteristics and epidemiological profile of Buruli ulcer in the district of Tiassale, south cote d’Ivoire. Acta Trop 175:138–144
    1. Brou T, Broutin H, Elguero E, Asse H, Guegan JF (2008) Landscape diversity related to Buruli ulcer disease in cote d’Ivoire. Plos Neglect Trop D 2(7):e271
    1. Wu J, Tschakert P, Klutse E, Ferring D, Ricciardi V, Hausermann H et al (2015) Buruli ulcer disease and its association with land cover in southwestern Ghana. PLoS Negl Trop Dis 9(6):e0003840
    1. N’Krumah RT, Kone B, Tiembre I, Cisse G, Pluschke G, Tanner M et al (2016) Socio-environmental factors associated with the risk of contracting Buruli ulcer in Tiassale, south cote d’Ivoire: a case-control study. PLoS Negl Trop Dis 10(1):e0004327
    1. Aboagye SY, Asare P, Otchere ID, Koka E, Mensah GE, Yirenya-Tawiah D et al (2017) Environmental and behavioral drivers of Buruli ulcer disease in selected communities along the Densu River basin of Ghana: a case-control study. Am J Trop Med Hyg 96(5):1076–1083
    1. Aiga H, Amano T, Cairncross S, Adomako J, Nanas OK, Coleman S (2004) Assessing water-related risk factors for Buruli ulcer: a case-control study in Ghana. Am J Trop Med Hyg 71(4):387–392
    1. Sopoh GE, Barogui YT, Johnson RC, Dossou AD, Makoutode M, Anagonou SY et al (2010) Family relationship, water contact and occurrence of Buruli ulcer in Benin. PLoS Negl Trop Dis 4(7):e746
    1. Maman I, Tchacondo T, Kere AB, Piten E, Beissner M, Kobara Y et al (2018) Risk factors for Mycobacterium ulcerans infection (Buruli ulcer) in Togo horizontal line a case-control study in Zio and Yoto districts of the maritime region. BMC Infect Dis 18(1):48
    1. Hinds DA, Stuve LL, Nilsen GB, Halperin E, Eskin E, Ballinger DG et al (2005) Whole-genome patterns of common DNA variation in three human populations. Science 307(5712):1072–1079
    1. Menashe I, Rosenberg PS, Chen BE (2008) PGA: power calculator for case-control genetic association analyses. BMC Genet 9:36
    1. Bibert S, Bratschi MW, Aboagye SY, Collinet E, Scherr N, Yeboah-Manu D et al (2017) Susceptibility to Mycobacterium ulcerans disease (Buruli ulcer) is associated with IFNG and iNOS gene polymorphisms. Front Microbiol 8:1903
    1. Stienstra Y, van der Werf TS, Oosterom E, Nolte IM, van der Graaf WT, Etuaful S et al (2006) Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism. Genes Immun 7(3):185–189
    1. Capela C, Dossou AD, Silva-Gomes R, Sopoh GE, Makoutode M, Menino JF et al (2016) Genetic variation in autophagy-related genes influences the risk and phenotype of Buruli ulcer. PLoS Negl Trop Dis 10(4):e0004671
    1. Goswami T, Bhattacharjee A, Babal P, Searle S, Moore E, Li M et al (2001) Natural-resistance-associated macrophage protein 1 is an H+/bivalent cation antiporter. Biochem J 354(Pt 3):511–519
    1. Manzanillo PS, Ayres JS, Watson RO, Collins AC, Souza G, Rae CS et al (2013) The ubiquitin ligase parkin mediates resistance to intracellular pathogens. Nature 501(7468):512–516
    1. Zimmermann P, Finn A, Curtis N (2018) Does BCG vaccination protect against non-Tuberculous mycobacterial infection? A systematic review and meta-analysis. J Infect Dis 218(5):679–687
    1. The Uganda Buruli group (1969) BCG vaccination against mycobacterium ulcerans infection (Buruli ulcer). First results of a trial in Uganda. Lancet 1(7586):111–5
    1. Smith PG, Revill WD, Lukwago E, Rykushin YP (1976) The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemic area of Uganda. Trans R Soc Trop Med Hyg 70(5–6):449–457
    1. Nackers F, Dramaix M, Johnson RC, Zinsou C, Robert A (2006) E DEBB, et al. BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin. Am J Trop Med Hyg 75(4):768–774
    1. Phillips RO, Phanzu DM, Beissner M, Badziklou K, Luzolo EK, Sarfo FS et al (2015) Effectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo. PLoS Negl Trop Dis 9(1):e3457
    1. Ahoua L, Guetta AN, Ekaza E, Bouzid S, N’Guessan R, Dosso M (2009) Risk factors for Buruli ulcer in cote d’Ivoire: results of a case-control study, august 2001. Afr J Biotechnol 8(4):536–546
    1. Johnson RC, Nackers F, Glynn JR, de Biurrun Bakedano E, Zinsou C, Aguiar J et al (2008) Association of HIV infection and Mycobacterium ulcerans disease in Benin. AIDS 22(7):901–903
    1. Christinet V, Comte E, Ciaffi L, Odermatt P, Serafini M, Antierens A et al (2014) Impact of human immunodeficiency virus on the severity of buruli ulcer disease: results of a retrospective study in Cameroon. Open Forum Infect Dis 1(1):ofu021
    1. Tuffour J, Owusu-Mireku E, Ruf MT, Aboagye S, Kpeli G, Akuoku V et al (2015) Challenges associated with Management of Buruli Ulcer/human immunodeficiency virus Coinfection in a treatment Center in Ghana: a case series study. Am J Trop Med Hyg 93(2):216–223
    1. Bayonne Manou LS, Portaels F, Eddyani M, Book AU, Vandelannoote K, de Jong BC (2013) Mycobacterium ulcerans disease (Buruli ulcer) in Gabon: 2005-2011. Med Sante Trop 23(4):450–457
    1. Toll A, Gallardo F, Ferran M, Gilaberte M, Iglesias M, Gimeno JL et al (2005) Aggressive multifocal Buruli ulcer with associated osteomyelitis in an HIV-positive patient. Clin Exp Dermatol 30(6):649–651
    1. Komenan K, Elidje EJ, Ildevert GP, Yao KI, Kanga K, Kouame KA et al (2013) Multifocal Buruli ulcer associated with secondary infection in HIV positive patient. Case Rep Med 2013:348628
    1. Johnson RC, Ifebe D, Hans-Moevi A, Kestens L, Houessou R, Guedenon A et al (2002) Disseminated Mycobacterium ulcerans disease in an HIV-positive patient: a case study. AIDS 16(12):1704–1705
    1. Bafende AE, Lukanu NP, Numbi AN (2002) Buruli ulcer in an AIDS patient. S Afr Med J 92(6):437
    1. Kibadi K, Colebunders R, Muyembe-Tamfum JJ, Meyers WM, Portaels F (2010) Buruli ulcer lesions in HIV-positive patient. Emerg Infect Dis 16(4):738–739
    1. O’Brien DP, Ford N, Vitoria M, Christinet V, Comte E, Calmy A et al (2014) Management of BU-HIV co-infection. Tropical Med Int Health 19(9):1040–1047
    1. Junghanss T, Johnson RC, Pluschke G (2014) Mycobacterium ulcerans disease. In: Farrar J, Hotez PJ, Junghanss T, Kang G, Lalloo D, White NJ (eds) Manson’s tropical diseases, 23rd edn. Saunders, Edinburgh, pp 519–531
    1. Nakanaga K, Hoshino Y, Yotsu RR, Makino M, Ishii N (2011) Nineteen cases of Buruli ulcer diagnosed in Japan from 1980 to 2010. J Clin Microbiol 49(11):3829–3836
    1. Fyfe JA, Lavender CJ, Johnson PD, Globan M, Sievers A, Azuolas J et al (2007) Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples. Appl Environ Microbiol 73(15):4733–4740
    1. Klis S, Stienstra Y, Phillips RO, Abass KM, Tuah W, van der Werf TS (2014) Long term streptomycin toxicity in the treatment of Buruli ulcer: follow-up of participants in the BURULICO drug trial. PLoS Negl Trop Dis 8(3):e2739
    1. O’Brien DP, Jenkin G, Buntine J, Steffen CM, McDonald A, Horne S et al (2014) Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update. Med J Aust 200(5):267–270
    1. Vogel M, Bayi PF, Ruf MT, Bratschi MW, Bolz M, Um Boock A et al (2016) Local heat application for the treatment of Buruli ulcer: results of a phase II open label single center non comparative clinical trial. Clin Infect Dis 62(3):342–350
    1. Renzaho AM, Woods PV, Ackumey MM, Harvey SK, Kotin J (2007) Community-based study on knowledge, attitude and practice on the mode of transmission, prevention and treatment of the Buruli ulcer in Ga West District, Ghana. Tropical Med Int Health 12(3):445–458
    1. Mulder AA, Boerma RP, Barogui Y, Zinsou C, Johnson RC, Gbovi J et al (2008) Healthcare seeking behaviour for Buruli ulcer in Benin: a model to capture therapy choice of patients and healthy community members. Trans R Soc Trop Med Hyg 102(9):912–920
    1. Koka E, Yeboah-Manu D, Okyere D, Adongo PB, Ahorlu CK (2016) Cultural understanding of wounds, Buruli ulcers and their Management at the Obom sub-district of the Ga south municipality of the Greater Accra region of Ghana. PLoS Negl Trop Dis 10(7):e0004825
    1. Peeters Grietens K, Toomer E, Um Boock A, Hausmann-Muela S, Peeters H, Kanobana K et al (2012) What role do traditional beliefs play in treatment seeking and delay for Buruli ulcer disease?--insights from a mixed methods study in Cameroon. PLoS One 7(5):e36954
    1. Grietens KP, Boock AU, Peeters H, Hausmann-Muela S, Toomer E, Ribera JM (2008) “It is me who endures but my family that suffers”: social isolation as a consequence of the household cost burden of Buruli ulcer free of charge hospital treatment. PLoS Negl Trop Dis 2(10):e321
    1. Amoakoh HB, Aikins M (2013) Household cost of out-patient treatment of Buruli ulcer in Ghana: a case study of Obom in Ga south municipality. BMC Health Serv Res 13:507
    1. Chukwu JN, Meka AO, Nwafor CC, Oshi DC, Madichie NO, Ekeke N et al (2017) Financial burden of health care for Buruli ulcer patients in Nigeria: the patients’ perspective. Int Health 9(1):36–43
    1. Amoussouhoui AS, Sopoh GE, Wadagni AC, Johnson RC, Aoulou P, Agbo IE et al (2018) Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa. PLoS Negl Trop Dis 12(3):e0006291
    1. Ayelo GA, Anagonou E, Wadagni AC, Barogui YT, Dossou AD, Houezo JG et al (2018) Report of a series of 82 cases of Buruli ulcer from Nigeria treated in Benin, from 2006 to 2016. PLoS Negl Trop Dis 12(3):e0006358
    1. Tabah EN, Nsagha DS, Bissek AC, Njamnshi AK, Bratschi MW, Pluschke G et al (2016) Buruli ulcer in Cameroon: the development and impact of the national control Programme. PLoS Negl Trop Dis 10(1):e0004224
    1. Mitja O, Marks M, Bertran L, Kollie K, Argaw D, Fahal AH et al (2017) Integrated control and Management of Neglected Tropical Skin Diseases. PLoS Negl Trop Dis 11(1):e0005136
    1. Barogui YT, Diez G, Anagonou E, Johnson RC, Gomido IC, Amoukpo H et al (2018) Integrated approach in the control and management of skin neglected tropical diseases in Lalo, Benin. PLoS Negl Trop Dis 12(6):e0006584

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться